908 Devices Inc. (MASS) vs Pacific Biosciences of California, Inc. (PACB)
- 908 Devices Inc. MASS 11.33 −4.71%
- Pacific Biosciences of California, Inc. PACB 1.73 −11.73%
908 Devices Inc. and Pacific Biosciences of California, Inc. are both Medical Devices companies. Pacific Biosciences of California, Inc. is the larger, with a market value of $609.2M against $491.5M — 1.2× the size. 908 Devices Inc. grew revenue faster over the last twelve months: 13.4% against 2.02%. 908 Devices Inc. has the higher net margin (−57.0% vs −82.5%) and the lower return on invested capital (−96.4% vs −22.2%). Across the 17 metrics below, 908 Devices Inc. leads on 11 and Pacific Biosciences of California, Inc. on 6.
Valuation
Profitability
| Metric | MASS | PACB | Medical Devices median |
|---|---|---|---|
| Gross margin | 52.16% | 36.38% | 56.01% |
| Operating margin | (63.98%) | (83.53%) | (15.03%) |
| Net margin | (56.96%) | (82.49%) | (20.40%) |
| Free cash flow margin | 1.01% | (50.53%) | (7.24%) |
| Return on equity | (25.15%) | (929.31%) | (15.32%) |
| Return on assets | (17.81%) | (16.66%) | (19.72%) |
| Return on invested capital | (96.41%) | (22.22%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack